(November 23 2011; Stemedica Cell Technologies, Inc.)
The Geron Corporation, a biopharmaceutical company that was developing cell therapy products from differentiated human embryonic stem cells for multiple indications, recently announced that they have decided to exit the stem cell industry citing financial reasons and what is perceived to be a very long regulatory pathway for its embryonic stem cell technology
There are many opinions on how this news will impact the stem cell industry. Please read our response below.
Geron Exits Stem Cell Industry: Stemedica Response
Advertisement
